Intraoperative fluorescein angiography using an ophthalmic endoscope - Intraoperative fluorescein angiography

Kaga Tatsushi0 sites40 target enrollmentNovember 14, 2019

Overview

Phase: 未知
Intervention: Not specified
Conditions: Diabetic retinopathy. Uveitis. Age-related macular degeneration. Rubeotic glaucoma.
Sponsor: Kaga Tatsushi
Enrollment: 40
Status: Recruiting
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

November 14, 2019

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Kaga Tatsushi

•Patients who sufficiently understand this study, agree to participate in this study after receiving sufficient explanation and obtain written informed consent under their own will.
•Patients older than 20 and under 85 years old at the time of informed consent acquisition.
•Patients whose blood circulation evaluation by intraoperative fluorescein angiography (FA) using an ophthalmic endoscope are thought to be useful, and who require intraocular surgery.
•Specifically, the following patients.
•Patients with difficulty in evaluating the fundus with normal FA test due to small pupil, severe cataract, vitreous hemorrhage or vitreous opacity. Or patients who may have neovascular or non perfusion area in the peripheral retina, under the retina, at the back of the iris, or at angle that can not be visualized by normal FA test, subjects are shown below.
•\- Diabetic retinopathy
•\- Familial exudative vitreoretinopathy
•\- Retinal detachment secondary to atopic dermatitis, uveitis or retinal vein occlusion
•\- Age related macular degeneration
•\- Neovascular glaucoma

•Patients who previously examined FA test and have experienced adverse reactions or poor physical condition due to contrast media.
•Patients who previously had severe food or drug allergies.
•Patients who have severe hepatic dysfunction.
•Patients who have severe hypertension (grade III hypertension).
•Pregnant woman, maternal, lactating woman.
•Patients who show the following abnormalities in screening tests.
•\- Systolic blood pressure is higher than 180 mmHg or diastolic blood pressure is more than 120 mmHg.
•\- AST or ALT is higher than 100 IU/L.
•Patients who are considered inappropriate to participate in this study by the principal investigator or subinvestigator.